Seattle Genetics CEO Clay Siegall: An Interview With “The Pink Sheet” DAILY (Part 1 Of 2)
Biotech chief exec sits down to talk about the comprehensive development program for SGN-40 in cancer and partnering with Genentech.
Biotech chief exec sits down to talk about the comprehensive development program for SGN-40 in cancer and partnering with Genentech.